tailieunhanh - Refinement of response assessment in neuro-oncology (RANO) using nonenhancing lesion type and contrast enhancement evolution pattern in IDH wild-type glioblastomas

Updated response assessment in neuro-oncology (RANO) does not consider peritumoral nonenhancing lesion (NEL) and baseline (residual) contrast enhancement (CE) volume. The objective of this study is to explore helpful imaging characteristics to refine RANO for assessing early treatment response (pseudoprogression and time-to-progression [TTP]) in patients with IDH wild-type glioblastoma. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN